Tongshu Gene Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $14.2M

  • Investors
  • 11

Tongshu Gene General Information

Description

Provider of gene testing services intended to improve tumor precision medicine. The company develops diagnostic molecular pathology projects and ctDNA precision detection systems based on high-throughput gene sequencing technology and biological information analysis, providing clinicians with consulting services including precision medication, efficacy monitoring, postoperative recurrence monitoring, risk prediction and early detection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Building B2
  • No. 9 Changyang Road, Xitaihu Science and Technology Industrial Park
  • Changzhou, Jiangsu
  • China
+86 021
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2nd Floor, Building B2
  • No. 9 Changyang Road, Xitaihu Science and Technology Industrial Park
  • Changzhou, Jiangsu
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tongshu Gene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 14-Oct-2024 $14.2M Completed Generating Revenue
3. Later Stage VC (Series C) 15-Jun-2021 Completed Generating Revenue
2. Early Stage VC (Series B) 22-Sep-2020 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Feb-2018 Completed Generating Revenue
To view Tongshu Gene’s complete valuation and funding history, request access »

Tongshu Gene Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Bohua Capital Venture Capital Minority
China Galaxy Securities Corporation Minority
GL Capital Group Growth/Expansion Minority
Haier Financial Holdings Fund of Funds Minority
Haier Group Corporation Minority
You’re viewing 5 of 11 investors. Get the full list »

Tongshu Gene Investments (1)

Tongshu Gene’s most recent deal was a Secondary Transaction - Private with Fangcheng Medical Laboratory. The deal was made on 29-Dec-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Fangcheng Medical Laboratory 29-Dec-2018 Secondary Transaction - Private Laboratory Services (Healthcare)
To view Tongshu Gene’s complete investments history, request access »

Tongshu Gene FAQs

  • When was Tongshu Gene founded?

    Tongshu Gene was founded in 2016.

  • Where is Tongshu Gene headquartered?

    Tongshu Gene is headquartered in Changzhou, China.

  • What industry is Tongshu Gene in?

    Tongshu Gene’s primary industry is Laboratory Services (Healthcare).

  • Is Tongshu Gene a private or public company?

    Tongshu Gene is a Private company.

  • What is Tongshu Gene’s current revenue?

    The current revenue for Tongshu Gene is .

  • How much funding has Tongshu Gene raised over time?

    Tongshu Gene has raised $92.2M.

  • Who are Tongshu Gene’s investors?

    Beijing Bohua Capital, China Galaxy Securities, GL Capital Group, Haier Financial Holdings, and Haier Group are 5 of 11 investors who have invested in Tongshu Gene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process